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1. Introduction 
Oral cancer has become a global health problem (Parkin, 2005; Gillison, 2007) and its 
increasing incidence and mortality rates are particularly relevant in certain parts of Europe 
(France, Hungary, Spain and Croatia), Brazil, and South-Eastern Asia (Sri Lanka, Pakistan, 
Bangladesh and India) (Warnakulasuriya, 2009). These geographical variations seem to 
reflect disparities in tobacco, areca nut and alcohol consumption (Warnakulasuriya, 2009). 
Worldwide, oral cancer has one of the lowest survival rates that remains unaltered despite 
recent therapeutic advances. Young adults seem to be growingly affected by tongue cancer 
in Brazil, several European countries and USA (Llewellyn, 2004). However, current reports 
describe a trend –more marked for tongue carcinomas- towards improved survival at each 
stage and at all ages but ≥75 years (Pulte, 2010).  
Search for prognostic markers for oral cancer has been extensive and thorough with diverse 
results: age, gender, immunological or nutritional status, size and location of the tumour, 
disease stage, nodal status, oncogene expression, proliferation markers, or DNA content 
have been allocated independent prognostic value (Johnson, 1996); but tumour stage at 
diagnosis remains the most important prognostic maker for oral squamous cell carcionoma 
(Garzino-Demo, 2006). Unfortunately, almost half of the oral neoplasms are diagnosed at 
stages III or IV, with 5-year survival rates ranging from 20% to 50% depending upon tumour 
sites (Holmes, 2003; Brandizzi, 2005). 
Early detection is widely recognised as the cornerstone to reduce diagnostic delay and, thus, 
to improve survival (De Faria , 2003; McDowell, 2006). However, this term (early detection) 
is not free from confusion as can be understood either as “a relative small tumour in size at 
the time of detection” or as “short time interval since cancer onset to diagnosis” (diagnostic 
delay) (van der Waal, 2011). 
2. Early detection. Diagnosis of small-size oral carcinoma 
Tumour size influences therapy and prognosis of oral cancer. Diagnosis of larger oral 
carcinomas has been linked to an increased risk of neck-node metastases and poor survival 
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(Woolgar, 1999). Lately, this variable (plain clinical or pathological tumour size) has been 
replaced by tumour thickness or depth of invasion as more significant prognostic factors 
(Gonzalez-Moles, 2002; O-charoenrat, 2003). Moreover, tumour thickness has proved 
independent predictive value for subclinical node metastases, local recurrence and survival 
(Po Wing Yuen, 2002). Accordingly, a critical thickness of 4 mm has been proposed, above 
which the risk for metastases is 4 times the risk of tumours with minor invasion depth 
(Ambrosch, 1995). Generally speaking, a small-size tumour should present a diameter 
inferior than 2 cm, less than 4 mm of invasion depth and usually asymptomatic (Woolgar, 
2006). Thus, clinicians are recommended to be watchful on the signs of potentially 
malignant lesions or early stage cancers in all patients, but particularly on heavy smokers 
and alcohol consumers. These signs include indurations, bleeding, exophytic growths larger 
than 1 mm, chronic ulcerations with irregular, dirty or spotty appearance in lesions that do 
not disappear after the hypothetical causal agents have been removed, together with texture 
changes or granulation on the surface of the lesion. Moreover, keeping in mind that 
persistent erythroplastic lesions are the most frequent clinical presentation of early 
carcinomas (Mashberg, 1977; Mashberg, 1988; Bouquot, 1995) (Figure 1) along with erythro-
leukoplastic (23%) and leukoplastic lesions (21%) may ease an early diagnosis of oral cancer 
(Mashberg, 1995). 
 
 
 
Fig. 1. Erythroplastic oral squamous cell carcinoma. 
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3. Diagnostic delay in oral cancer. Concept 
The concept of diagnostic delay would comprise the time since first sign or symptom to 
definitive diagnosis. This fairly clear concept has been studied from different points of view 
with heterogeneous criteria (Allison, 1998a; Allison, 1998b; Allison, 1998c), resulting in 
categorisations that include: “patient delay”: the period between the patient first noticing a 
symptom and the first consultation with a health professional about the symptom; and 
“professional delay”: the period from patient’s first consultation with a clinician to the 
definitive pathological diagnosis”. This categorisation can be broken down further to 
include the “delay by patients”: time until consultation due to inaccessibility to the 
healthcare provider (Allison, 1998a; Allison, 1998b; Allison, 1998c; Onizawa, 2003) –which is 
not always due to the patients-. To overcome this ambiguity, the term “scheduling delay” 
(period between the patient making an appointment and actually seeing a healthcare 
professional) was introduced (Diz-Dios, 2005) (Figure 2). 
 
Fig. 2. Types of diagnostic delay in oral cancer.  
Despite these efforts, to date there is no consensus on a time-point beyond which a cancer 
diagnosis can be considered delayed. Several research groups have used the mean or the 
median of the time distribution to categorise diagnostic delay (Andersen, 1995; Pitiphat, 
2002; Carvalho, 2002; Gorsky, 1995), the latter being more frequent as it is not affected by the 
extreme values of distributions that usually show very wide ranges. Other authors choose 
an arbitrary time-point (more than thirty days) to discriminate between delayed and non-
delayed cases (Allison, 1998a; Allison, 1998b; Allison, 1998c; Brouha, 2005), in order to allow 
time for the patient to identify the symptoms, seek consultation, for a follow up of 7-10 days 
and a second consultation and biopsy, and, finally for the pathologist to report the results 
back to the clinician (Gorsky, 1995). 
Other criteria include a first stage: since the first symptom until the first contact with the 
clinician; a second stage: since the first visit until a referral letter is written; a third stage: 
since the patient gets the referral letter until the first consultation at a specialised service; 
and a 4th stage, since the first consultation to a specialist until a definitive diagnosis is 
reached (Onizawa, 2003). As can be inferred, this approach introduces some degree of 
complexity and limits the external validity of the studies performed under this scheme. 
Regardless of the importance of this topic, it is somehow surprising the limited number of 
reports dealing with the influence of diagnostic delay in head and neck carcinomas 
retrievable from scientific databases, particularly when compared to melanoma or 
colorectal, breast, and bladder carcinomas. 
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4. Causes of oral cancer diagnostic delay 
The proportion of patients receiving a delayed definitive diagnosis of oral cancer remains 
high worldwide, with wide variations in the values reported: in Greece more than a half of 
oral cancer patients are diagnosed with delays longer than 3 weeks (Pitiphat, 2002), whereas 
Dutch and Spanish patients are diagnosed with an average delay of 1.5 months (Kowalsky, 
1994; Seoane, 2006); series published from Canada, Italy, Denmark or Israel report medians 
of diagnostic delays ranging from 3 to four months (Allison, 1998a; Allison, 1998b; Allison, 
1998c; Wildt, 1995; Gorsky, 1995 ). 
Undoubtedly, there are potential factors responsible for late diagnosis of oral cancer: on the 
one hand, psychosocial factors related to the patient may well condition the perception of 
the cancer symptoms by the individual and lead him/her to erroneous behavioural 
responses that may adversely affect his/her demands and access to care. This may explain 
why the use of traditional herbal medication before visiting a healthcare professional is 
recognised as a significant independent predictor for patient delay in Thailand (Kerdpon, 
2001a; Kerdpon, 2001b). 
On the other hand, the accessibility (ability to obtain services based on oral health needs) 
can be limited by financial, structural and personal barriers (beliefs, language) and thus 
decisively conditioning the timing of oral cancer diagnosis (Seoane, 2010). Disparities in 
access to oral health services across Europe and USA are well known, particularly for low-
income populations (uninsured, migrant, homeless, etc). Ethno-regional differences have 
also been identified in terms of incidence and mortality rates of oral cancer, which may 
result from the variation in the access to oral care but also from the different exposition to 
risk factors or from the limited resources in detection and prevention methods available to 
these individuals. 
The causes of diagnostic delay related to the clinician are particularly interesting, and can be 
basically due to not to practice a full clinical examination (Bruun, 1976), the presence of 
unspecific or banal clinical signs (Bruun, 1976), low index of suspicion and lack of 
familiarity and experience with the disease (Guggenheimer, 1989). Co-morbidity has also 
been suggested (Allison, 1998a; Allison, 1998b; Allison, 1998c), as clinicians in these 
situations tend to focus their attention on the existing disorders. 
Lack of oral cancer knowledge has also been described to influence delays in referral and 
treatment (Colella, 2008; Seoane 2010), and this situation has been detected internationally 
as a worrying lack of knowledge on diagnostic procedures, main locations of oral cancer 
(Alonge, 2003) and on leuko- or erythroplakia-like carcinomas as primary oral cancer 
lesions, as well as on the effects of vegetable intake on the incidence of oral cancer. 
Conversely, facts like squamous cell carcinoma being the most common histopathologial 
type or oral cancer, criteria for referral of patients with suspicious lesions, that early 
detection improves the 5-year survival rate and that tobacco and alcohol are risk factors for 
oral cancer (Seoane 2010) are well known by the healthcare professionals. 
In short, diagnostic delay is a complex concept conditioned by tumour biology, patient 
behaviour, clinician awareness and attitudes, as well as by the healthcare system 
performace. 
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5. Other factors related to late stage diagnosis of oral squamous cell 
carcinoma 
Although recognition of predictors for advanced-stage diagnosis could permit the 
implementation of strategies for increasing the number of oral carcinomas diagnosed at an 
early stage, there is no much information on this issue. 
The most frequently studied variables (age, gender, and tobacco and alcohol intake) are not 
linked to late-stage diagnosis, as were not previously associated to professional or patient-
related delays (Boing, 2010; Guggenheimer 1989). Neither precancerous lesions connected to 
the tumour seem to modify the spread of the disease at diagnosis, even when proliferative 
verrucous leukoplakia or the presence of mild to moderate epithelial dysplasia at the 
margins of a surgically removed oral squamous cell carcinoma carries a significant risk of 
local recurrence and modifies the prognosis of the disorder (Thomsom, 2007). 
Ulcerated-type oral squamous cell carcinomas are usually diagnosed at stages III or IV 
(Jaulerry, 1985) (Figure 3). Although the predictive value of the clinical appearance of the 
primary lesion remains controversial, it is accepted that ulcerated lesions imply poorer 
survival rates (Jaulerry, 1985). 
 
 
Fig. 3. Ulcerated-type tongue squamous cell carcinoma. 
The site of the primary lesion has been also linked either to delayed diagnosis or diagnosis 
at advanced stages (Brouha, 2005): tongue, buccal mucosa and lip carcinomas seem to be 
diagnosed at earlier stages (Gorsky, 1995) than floor of the mouth and retromolar trigone 
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neoplasms; whereas palate or gingival tumours showed contradictory results (Gorsky, 
1995). Accordingly, the floor of the mouth, gingivae and retromolar trigone have recently 
been identified as independent prognostic factors for late-stage diagnosis, which may well 
be explained by the fact that patients’ self-perception and self-exploration abilities are 
conditioned by the site of the tumour (Andersen, 1995); the presence of the gingivae within 
this group would be due to the association of gingival locations to advanced stage at 
diagnosis (late diagnosis) caused by the early invasion of the nearby bone (T4 primary 
tumour) (Seoane, 2006). 
Late diagnosis of neoplasms, particularly in oral cancer, has been conventionally ascribed to 
delays in reaching a diagnosis, as patients at advanced tumour stages are more likely to 
have experienced longer patient and professional delays than those diagnosed at earlier 
stages (Sargeran, 2009). Surprisingly, there is an evident lack of sound scientific evidence 
supporting this traditional association between diagnostic delay and disease extension (III-
IV TNM stages) (Gomez, 2009; Gomez, 2010). 
The biological behaviour of the tumour has also been investigated as an hypothetical 
predictor for a late-stage diagnosis, with positive results, as poorly differentiation of a 
tumour (biologically more aggressive) proved to be an independent risk factor for diagnosis 
at stages III and IV, which may suggest that the TNM stage of a tumour when diagnosed 
could be affected more by the biology of the cancer (degree of differentiation) than by a 
delay in the diagnosis.  
6. Relationships between diagnostic delay in primary oral cancer and disease 
extension 
Tumour size and nodal status seem to correlate well with tumour growth chronology in oral 
cancer (Spiro, 1986; Brown, 1989; Parker, 1996). This paradigm leaded to investigations on 
the feasibility that diagnostic delay contributes to the spread of the disease. Despite this 
theory could be proved for certain tumours (Erwenne, 1989; Porta , 1991; Faccione, 1993), no 
definitive conclusions could be drawn for oral cancer, where disagreements between the 
groups who discard an association (Allison et al, 1998; Kantola et al, 2001; Kerdpon et al, 
2001b) and those who endorse it (O’Sullivan, 2001; Brouha et al, 2005b, Gomez et al., 2009) 
are evident. 
The paper by Guggenheimer et al (1989) was one of the first in considering this hypothetical 
relationship in a mixed sample of 149 oral and pharyngeal cancers and failed to identify an 
association even after considering patient and professional delays separately. From then on, 
this has been a common conclusion in the literature (Jovanovic et al, 1992; Amir et al, 1999; 
Hollows et al, 2000; Kerdpon et al, 2001a; Kerdpon et al 2001b) until 1994, when Kowalski et al. 
significantly related professional delay and tumour stage, but not between overall delay and 
spread of the disease, which may suggest the relevance of memory bias in this particular 
type of research. 
The control of biases is a challenging issue for researchers in this field. The consideration 
of patient survival as the research outcome and the use of multivariate analysis to adjust 
for confounding factors (Wildt et al, 1995) meant an improvement in the design of these 
studies but the sought association could not still be identified for oral cancer (Wildt et al , 
1995) or for mixed samples of head and neck carcinomas (Gorsky & Dyan, 1995). Research 
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designs were further improved by the combination of data collection methods to include 
prospective and retrospective data for reducing memory bias: McGurk et al (2005) 
gathered a sample of 613 cases over 40 years and failed to unveil a relationship between 
delay in diagnosis and tumour stage but they used an arbitrary time point of three 
months to distinguish between delayed and non-delayed cases in their mixed sample of 
head and neck cancers that, combined with a vague definition of diagnostic delay, 
compromise their conclusions. 
The composition of the study sample may be relevant, since Scott et al (2005) found no 
relationship between diagnostic delay and tumour stage, but discovered a trend in this 
direction for certain oral sites. Carvalho et al (2002) somehow confirmed this trend in their 
series of 676 head and neck squamous cell carcinomas when observed that laryngeal and 
hypopharyngeal cancers were more prone to be diagnosed at advanced stages than lip, oral 
and oropharyngeal neoplasms. Additional light in this course was provided by Allison et al 
(1998c) who demonstrated that patients with upper aerodigestive tract carcinomas with 
professional delays longer than 1 month had an increased risk to be diagnosed at late stage. 
When dealing with diagnostic delay, the beginning of any study is, unavoidably, the 
recognition of the signs and symptoms by the patient, and this recognition is undoubtedly 
affected by his/her psychosocial characteristics. The first group in considering these 
variables was that of Kumar et al (2001) who identified a significant relationship between 
overall diagnostic delay and tumour stage in their sample of 79 patients. Similar findings 
were reported by Pitiphat et al (2002) from a case-control study, demonstrating that the 
length of diagnostic delay was significantly greater in patients with advanced tumour stages 
(TNM stage IV). 
There is no sound scientific evidence supporting an association between diagnostic delay in 
oral cancer, extension of the disease diagnosed at advancer stages (TNM III-IV) and lower 
survival rates. However, this fact is probably due to methodological flaws in the published 
reports to date (Allison, 1998a; Allison, 1998b; Allison, 1998c). These reports use different 
conceptions of diagnostic delay and are thus liable to misclassifications; use retrospective 
designs without strategies to diminishing patients’ memory bias and often break down 
diagnostic delay classifications to groups with insufficient sample size. Moreover, the study 
of samples with heterogeneous cancer sites introduce confounding factors in the analysis, as 
the patient’s self-perception and self- exploration abilities depend on the site of the tumour 
(Allison et al, 1998a; Tromp et al, 2005; Wildt et al, 1995; O’Sullivan, 2001). For example, 
gingival locations are associated with advanced stages at diagnosis due to the early invasion 
of the adjacent bone tissue (T4 primary tumour) (Seoane et al., 2006) yet could present 
without time delay. Additional difficulties come from the type of data collected (e.g.: 
continuous variables (Wildt et al, 1995; Hollows et al 2000; Kumar et al, 2001; Kantola et al, 
2002) versus categorical (Allison et al 1998b; Kerdpon et al 2001a), from the different sources 
of patient data (questionnaires, interviews, clinical records) and also from the already 
mentioned patient memory bias. 
Different velocities of tumour growth may well also explain why some tumours remain 
small in size in spite of delay. Even though some studies related diagnostic delay and 
tumour stage (Brouha et al 2005), it is possible that the relationship between delay and 
advanced tumour stage is veiled by the fact that certain cancers remain silent during the 
initial stages and induce symptoms only when they reach and advanced phase (Scott, 2005). 
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This being, tumour growth rate would act as a confounding factor in the relationship 
between diagnostic delay and tumour stage, since patients with aggressive tumours and 
poor prognosis do not usually present diagnostic delay, while tumours with low 
proliferation rates demonstrate good prognosis despite long diagnostic delays (Kaufman, 
1980; Evans, 1982; Allison, 1998a). 
A recent meta-analytical study has shown that diagnostic delay is broadly associated to 
more advanced stages in oropharyngeal cancers. This association resulted to be specially 
strong when the analysis was restricted to oral cancer (pooled RR, 1.47; 95% CI: 1.09-1.99) 
and when the delay was longer than one month (pooled RR, 1-69; 95%CI: 1.26-2.77) 
(Gomez et al 2009). The probability for delayed patients to present an advanced stage of 
oral cancer at diagnosis in this report was 25% higher than that of non-delayed patient. 
Nevertheless these data should be interpreted with caution since all 9 studies considered 
in the analysis were cross-sectional in nature, with retrospective designs and a potential 
for recall bias. 
 
 
Study 
Tumour 
site 
Age-range 
(years) 
Gender 
M/F 
Delay 
Non-
advanced/Advanced
OR 
(95%CI) 
Guggenheimer, 1989 
Oral & 
OPH 
NS NS 54/19 0.5 (0.2-1.2) 
Gorsky,1995 
Oral & 
OPH 
10-99 363/180 259/1323 1.0 (0.5-2.1) 
Allison, 1998 
Oral & 
Pharynx 
34-91 134/54 67/84 3.0 (1.8-4.8) 
Kerdpon, 2000 Oral 32-93 117/44 42/78 1.7 (1.0-2.9) 
Kantola, 2001 Tongue 26-85 34/41 6/20 3.4 (1.0-11.7) 
Pitiphat, 2002 
Oral & 
Pharynx 
26-91 65/40 38/15 0.8 (0.3-2.3) 
Carvalho, 2002 
Oral & 
OPH 
15-82 363/54 78/224 0.8 (0.5-1.4) 
Onizawa, 2003 Oral 33-96 100/52 41/32 0.7 (0.3-1.4) 
Scott, 2004 Oral 22-89 157/88 48/59 1.3 (0.8-2.2) 
NS: not stated; OPH: Oropharynx; M: male; F: female; OR: odds ratio; CI: confidence interval 
Table 1. Association between diagnostic delay and advanced disease stage for oro 
pharyngeal carcinomas. 
7. Diagnostic delay and survival to oral cancer 
The number of studies focusing on the relationship between diagnostic delay and survival 
to oral cancer are scarce (Table 2), and their results show substantial discrepancies: on the 
one hand the strength of the association did not reach signification (Ho, 2004), but on the 
other hand there seems to exist a strong relationship when referral delay is considered 
(Kantola, 2001; Sandoval, 2009), more specifically: when longer than month, these delays 
worsen survival to oral and oropharyngeal cancer (Sandoval. 2009), however when tumour 
aggressiveness is considered, the role of diagnostic delay could not be demonstrated 
(Seoane, 2010). 
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Reports on tongue cancer are particularly paradoxical, as referral delays worsen survival, 
but professional delay behaves as a protective prognostic factor with shorter delays showing 
a trend towards impaired survival (Kantola, 2001; Teppo 2008). The impact of delays on 
survival was apparently unreasonable, as shorter delays impaired survival. This paradoxical 
circumstance, where diagnostic delay, tumour stage and tumour prognosis are inversely 
related, has been previously described in breast, cervix, lung, colon, renal and urethral 
cancer and seems to suggest that stage at diagnosis and survival are affected more by the 
biology of the cancer (rapid tumour growth) than by a delayed diagnosis.  
These conclusions demand more studies assessing the impact of diagnostic delay on the 
course of oral squamous cell carcinomas with sound epidemiologic design (prospective), 
standardised criteria for diagnostic delay and protocols to minimise recall bias. These future 
investigations would also benefit from considering in their statistical analyses the biological 
features of the tumour and treatment delays.  
 
 
Author Country
Data 
collection 
Tumor 
Site 
SS
TNM 
n (%) 
P D 
RR 
(95%CI) 
Prof D 
RR 
(95%CI)
Ref D 
RR 
(95%CI) 
T D 
RR 
(95%CI) 
Kantola Finland 1974-1994 Tongue 75
I  9  
(12% ) 
II 22 
(29.3%) 
III 33 
(44%) 
IV 11 
(14.7%) 
- - 
6.3 
(1.7-22.9) 
- 
Teppo Finland 1986-1996 Tongue 62
I  8 (13%)
II 22 (35%)
III 25 
(40%) 
IV 7 (11%)
0.58 
(0.36-0.93)
1.07 
(0.68-
1.70) 
- - 
Seoane Spain 1997-2002 Oral 63
I 9 (14.3%)
II 20 
(31.7%) 
III 10 
(15.9%) 
IV 24 
(38.1%) 
- - - 
1.0 
(0.9-1.1) 
Sandoval Spain 1996-1999 
Oral 
& 
OPH 
146
I 15 
(10.3%) 
II 30 
(20.5%) 
III 35 
(24%) 
IV 66 
(45.2%) 
- - 
2.1 
(1.0-4.3) 
- 
SS: sample size; PD: patient delay; Prof D: professional delay; Ref D: referral delay; TD: Total Delay;  
RR: relative risk; OPH: oropharyngeal 
Table 2. Reports on the association between diagnostic delay in oral cancer an survival. 
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This is important, as the clarification of this hypothetical relationship between diagnostic 
delay and survival to oral cancer may condition early oral cancer detection strategies either 
by strengthening programmes for diminishing diagnostic delay or favouring oral cancer and 
precancer screening strategies. 
8. Strategies to minimise diagnostic delay in oral cancer 
A delay when dealing with oral cancer diagnosis is unacceptable. Despite the quickness in 
obtaining a diagnosis does not ensure an early-stage tumour, it is essential for reducing cancer 
mortality (Horowitz, 1995). Specific educational interventions on the population, focused on 
risk groups (self-exploration) and on the clinicians (index of suspicion) are needed to achieve 
this goal. These interventions should provide sound knowledge of the disease presentation 
and competences for visual/tactile diagnosis. Additional improvements to ease accessibility to 
health care and the implementation of clear referral schemes for patients with suspicious 
lesions would also contribute to this purpose. An example of these schemes would be the 
“Two weeks wait”, rolled out in December 2000 in the United Kingdom for referral of head 
and neck cancer patients from primary care to specialised centres (Department of Health, 
2000). The audit of this programme showed a high proportion of non-malignant lesions being 
referred through the fast-track system, highlighting a low sensitivity among the general 
practitioners and stressing need for better visual detector guidelines. This assessment stressed 
the need for the primary care clinician to know which kind of cases should be sent to the 
specialist (all suspicious lesions and all suspicious borderline lesions). As it is difficult to detect 
oral cancer lesions at early stage, several ancillary diagnostic tests have been developed to 
improve diagnostic performance, such as toluidine blue staining, chemiluminiscence and 
autofluorescence (Trullenque –Eriksson, 2009). 
8.1 Toluidine blue 
Tolonium chloride (toluidine blue) has been assessed as diagnostic aid for diagnosis of oral 
malignant and premalignant lesions by a number of studies (Epstein, 2007; Epstein, 2008; 
Epstein, 2009). These results were studied from a meta-analytical perspective in 1989, 
revealing sensitivities ranging from 93.5% to 97.8% and specificities from 73.3% to 92.9% 
(Rosenberg, 1989), this good performance of the product was somehow spoiled by the 
serious methodological limitations observed in some of the original reports. A more recent 
report by Lingen (2008) described sensitivities for the detection of oral cancer ranging from 
0.78 to 1.00, and specificities of 0.31 to 1.00. A comprehensive analysis of the current 
evidence suggest that toluidine blue ins good at detecting carcinomas, but its sensitivity in 
detecting dysplasia is significantly lower (Epstein, 2008; Lingen, 2009). 
8.2 Light-based detection systems 
These systems are based upon the structural and metabolic changes the oral mucosa 
undergoes during the carcinogenesis process. These phenomena induce different absorbance 
and refractance profiles when exposed to different sources of light or energy (Epstein, 2009). 
8.2.1 Vizilite  (Zila Pharmaceuticals, Phoenix, AZ)  
A number of cross-sectional studies assessed this chemiluminiscence device with high 
scores in sensitivity (100%), as every patient had previously visualized mucosal lesions, but 
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low specificity values (0-14.2%) with high percentages of false positives. This device has 
proved a high capacity to emphasize certain visual features of the lesion, such as brightness 
and lesions limits (Epstein, 2009), but it does not aid in the identification of a premalignant 
or malignant oral lesion (Farah, 2007). A combination of Vizilite and toludine blue (ViziLite 
Plus) has been introduced to reduce the number of false positives but, although both 
specificity and predictive positive values improved, the scientific evidence on this 
combination published to date is scarce (Epstein, 2008). 
A different system based on the same principles of ViziLite (Microlux/DL, Danbury,USA) 
has been designed, which illuminates the lesion with a diffused light from a light-emitting 
diode. When assessed prospectively, it showed a sensitivity of 77.8% and a specificity of 
70.7% (McIntosh, 2009). Some reports point that chemoluminiscence could be useful to 
identify lesions hidden to incandescent light sources, but no evidence supports this theory. 
8.2.2 Tissue fluorescence imaging   
The VELscope system (Visually Enhanced Lesion Scope; LED Dental Inc., White Rock, 
USA) uses autoflorescence technology to detect the loss of fluorescence in visible and non-
visible oral lesions. Its sensitivity ranged from 97 to 100%, and proved useful to establish 
safer surgical margins in tumour excision (Huber, 2009), but no methodologically sound 
studies back the usefulness of this system as ancillary diagnostic tool when dealing with 
malignant or premalignant lesions in lower-risk, primary care patients (Lingen, 2008; 
Epstein, 2009). 
8.2.3 Tissue fluorescence spectroscopy 
This system produces various excitation wavelengths that are received by a spectrograph 
and recorded on a computer (Fedele, 2009). Its main advantage is the elimination of the 
subjective interpretation of the changes in the fluorescence of the tissues, but its main 
indication is limited to the exploration of previously visually-diagnosed small lesions. This 
device has shown a high sensitivity and specificity to differentiate healthy mucosa from 
malignant oral lesions (De Veld, 2005). 
Regardless of these promising technologies, the path until these systems enhance visual 
detection beyond what is achieved through conventional visual and tactile examinations is 
still to be covered. 
9. Oral cancer diagnosis at asymptomatic phases of the disease 
The studies on diagnostic delay consider only the symptomatic stage of the disease, which 
represents a minor part of the disease natural history. The equivocal relationship between 
diagnostic delay and certain outcomes of interest, like tumour stage and survival to the 
disease, suggest the need to prioritise the early diagnosis of oral cancer through screening 
programmes aimed at detecting the disease during its asymptomatic phases, as there is 
evidence demonstrating that oral visual inspection is satisfactorily sensitive to detect oral 
precancers and that can improve oral cancer stage at diagnosis. Moreover, community-
based screening on these bases may thus decrease oral cancer specific mortality amongst 
people who use tobacco, alcohol or both (Kujan, 2006). 
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However, it has to be born in mind that these kind of approaches can also be affected by 
biases, like the so-called “length-time bias”, where the possibility to detect aggressive oral 
carcinomas by screening is low due to the fact that the period until symptoms arise is short. 
On the other hand, less aggressive tumours with longer periods until symptoms are easier 
to detect by screening; this phenomena may make think that an early diagnosis improves 
prognosis, when what actually happens in that this approach detects mostly tumours 
biologically less aggressive (van der Waal, 2011). 
Another potential bias affecting this kind of programmes would be the “lead-time bias”, 
where survival to oral cancer may seem better when cases are diagnosed early but what 
actually happens is that cases are detected earlier though patients do not live longer than 
would live if the neoplasm were diagnosed during the symptomatic period of the disease 
(van der Waal, 2011). 
A different approach would be the case-search: the patient is explored searching for 
subclinical disease. This procedure is not so demanding but in any situation, the screening 
test should be easy, safe, reproducible and valid, as well as accepted by the population and 
by the healthcare workers involved, and should also assess risks, nuisances and costs. In 
areas with low prevalence of oral cancer, screening programmes result in a reduced 
detection rate. However, opportunistic high-risk screening (involves offering patients a 
screen when they attend a clinic for some other, unrelated reason), particularly in general 
dental practice, may be cost-effective (Conway, 2006). This screening may be more 
effectively targeted to younger age groups, chiefly 40-60 years old (Conway, 2006). 
Moreover, new educational strategies are needed to identify populations at particular risk; 
younger people (Farshadpour, 2007) and non-smoking and non-drinking oral cancer 
patients (females, old at disease presentation). Thus, the range of ages for systematic oral 
examination should be broaden. 
Opportunistic screening by general dentists includes a systematic review of the oral mucosa 
during regular dental care. About 83%-86% of European and American GDPs declared to 
perform a systematic exploration of oral soft tissues to rule out oral cancer. Despite this fact, 
their ability to make a correct positive detection of oral cancer (sensitivity) remains low, as 
reported scores varied from 0.4 to 1.0. The specificity ranged from 0.31 to 0.92; these low 
values would mean that patients with oral carcinomas would not be adequately referred for 
the decisive diagnosis and treatment (Downer, 2006). Despite that, selective opportunistic 
screening may be a realistic and effective solution, as detections of oral and oropharyngeal 
squamous cell carcinomas during a non-symptom-driven examination has demonstrated to 
be related to lower stages at diagnosis although there is insufficient evidence to determine 
whether screening by visual and tactile examination in asymptomatic patients alters disease-
specific mortality (Downer, 2006). Of course, it has to be kept in mind that “insufficient 
evidence” only means that there are no methodologically sound studies available to support 
a given technique or approach. 
10. References 
Alonge OK, & Naredran S. Opinions about oral cancer prevention and early detection 
among dentists practising along the Texas-Mexico border. Oral Dis. 2003;9:41-45. 
Allison P, Franco E, & Feine J. Predictors of professional diagnostic delays for upper 
aerodigestive tract carcinoma. Oral Oncology 1998(a);34:127-132. 
www.intechopen.com
 
Timing of Oral Cancer Diagnosis: Implications for Prognosis and Survival 
 
185 
Allison P, Franco E, Black M, & Feine J. The role of professional diagnostic delays in the 
prognosis of upper aerodigestive tract carcinoma. Oral Oncology 1998(b);34:147- 153. 
Allison P, locker D, & Feine J. The role of diagnostic delay in the prognosis of oral cancer: a 
review of the literature. Oral Oncology 1998(c); 34: 161-170. 
Ambrosch P, Kron M, & Fischer G. Micrometastases in carcinoma of the upper aerodigestive 
tract: detection, risk of metastasizing, and prognostic value of depth of invasión. 
Head Neck 1995; 17: 473–479. 
Amir Z, Kwan SYL, Landes D, Feber T, & Williams SA. Diagnostic delays in head and neck 
cancers. European Journal of Cancer Care 1999;8:198-203. 
Andersen BL, & Cacioppo JT. Delay in seeking a cancer diagnosis: delay stages and 
psychophysiological comparison processes. British Journal of Social Psychology 
1995;34:33-52. 
Boing AF, Ferreira Antunes JL, et al.. How much do smoking and alcohol consumption 
explain socioeconomic inequalities in head and neck cancer risk?. J Epidemiol 
Community Health. 2010 Aug 18. 
Bouquot JE, & Ephros H. Erythroplakia: the dangerous red mucosa, Pract Periodontics Aesthet 
Dent 1995; 7:59–67. 
Brandizzi D, Chuchurru J, Lanfranchi H, & Cabrini R. Analysis of the epidemiological features 
of oral cancer in the city of Buenos Aires. Acta Odontol Latinoam 2005; 18: 31-5. 
Brouha XDR, Tromp DM, Hordijk GJ, Winnubst JAM, & Leeuw RJ. Oral and pharyngeal 
cancer: analysis of patient delay at different tumor stages. Head and Neck 
2005;27:939-945. 
Brown B, Barnes L, Mazariegos J, Taylor F, Johnson J, & Wagner RL. Prognostic factors in 
mobile tongue and floor of the mouth carcinoma. Cancer 1989;64:1195-1202. 
Bruun JP. Time lapse by diagnosis of oral cancer. Oral surg Oral Med Oral Pathol 1976; 42: 
139-49. 
Carvalho AL, Pintos J, Schlecht NF, et al. Predictive factors for diagnosis of advanced-stage 
squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 
2002;128:313-318. 
Conway DI. To screen or not to screen? Is it worth it for oral cancer? Evid Based Dent. 
2006;7:81-2. 
De Faria PR, Cardoso SV, De A Nishioka S, et al. Clinical presentation of patients with oral 
squamous cell carcinoma when first seen by dentist or physician in a teaching 
hospital in Brazil. Clin Oral Invest. 2003;7:46-51. 
De Veld DC, Witjes MJ, Sterenborg HJ, & Roodenburg JL. The status of in vivo 
autofluorescence spectroscopy and imaging for oral oncology. Oral Oncology 
2005;41:117–31. 
Diz -Dios P, Padrón N, Seoane J, Tomas I, LimeresJ, & Varela-Centelles P. “Scheduling 
delay” in oral cancer diagnosis: a new protagonist. Oral Oncology 2005; 41:142-6. 
Downer M, Moles D, Palmer S, & Speight P. A systematic review of measures of 
effectiveness in screening for oral cancer and precancer.Oral Oncology. 
2006;42(6):551-60. 
Epstein JB, & Güneri P. The adjunctive role of toluidine blue in detection of oral premalignant 
and malignant lesions. Curr Opin Otolaryngol Head Neck Surg 2009;17:79–87.  
Epstein JB, Sciubba J, Silverman S, & Sroussi HY. Utility of toluidine blue in oral 
premalignant lesion and squamous cell carcinoma: continuing research and 
implications for clinical practice. Head Neck 2007;29:948–58.  
www.intechopen.com
 
Oral Cancer 
 
186 
Epstein J, Silverman S, Epstein J, Lonky S, & Bride M. Analysis of oral lesion biopsies 
identified and evaluated by visual examination, chemiluminescence and toluidine 
blue. Oral Oncology 2008;44:538–44.  
Erwenne CM, & Franco ELF. Age and lateness of referral as determinants of extra-ocular 
retinoblastoma. Opthal Pediatr Genetics 1989;10:179-184. 
Evans SJW, Langdon JD, Rapidis AD, & Johnson NW. Prognostic significance of STNMP 
and velocity of tumour growth in oral cancer. Cancer 1982;49:7773-776. 
Faccione N. Delay versus help seeking for breast cancer symptoms: a critical review of the 
literature on patient and provider delay. Social Science and Medicine 1993;36:1521- 1534. 
Farah CS, & McCullough MJ. A pilot case control study on the efficacy of acetic acid wash 
and chemiluminescence illumination (ViziLite) in the visualisation of oral mucosa 
white lesions. Oral Oncology 2007;43:820–4.  
Fedele S. Diagnostic aids in the screening of oral cancer. Head Neck Oncol 2009;I:5. 
Garzino-Demo P, Dell´Acqua A, Dalmasso P et al. Clinicopathological parameters and 
outcome of 245 patients operated for oral squamous cell carcinoma. J 
Craniomaxillofac Surg 2006; 34: 344-50. 
Gillison ML. Current topics in the epidemiology of oral cavity and oropharingeal cancers. 
Head & Neck 2007. Jan 17.  
Gómez I, Seoane J, Varela-Centelles P, Diz P, & Takkouche B. Is diagnostic delay related to 
advanced-stage oral cancer? A meta-analysis.Eur J Oral Sci. 2009 (b);117(5):541-6.  
Gómez I, Warnakulasuriya S, Varela-Centelles PI, López-Jornet P, Suárez M, Diz-Dios P, & 
Seoane J. Is early diagnosis of oral cancer a feasible objective? Who is to blame for 
diagnostic delay? Oral Dis. 2010 (a);16(4):333-42.  
Gonzalez-Moles. MA, Esteban F, Rodriguez-Archilla A, Ruiz-Avila I, & Gonzales-Moles S. 
Importance of tumour thickness measurement in prognosis of tongue cancer, Oral 
Oncol 2002; 38:394–397.  
Gorsky M, & Dayan D. Referral delay in diagnosis of oro/oropharyngeal cancer in Israel. 
Oral Oncol, Eur J Cancer 1995;31B:166-168. 
Guggenheimer J, Verbin RS, Johnson JT, Horkowitz CA, & Myers EN. Factors delaying the 
diagnosis of oral and oropharingeal carcinomas. Cancer 1989;64:932-935. 
Hollows P, McAndrew PG, & Perini MG. Delays in the referral and treatment of oral 
squamous cell carcinoma. Br Dent J 2000;188:262-265. 
Holmes JD, Dierks EJ, Homer LD, & Potter BE. Is detection of oral and oropharyngeal 
squamous cancer by a dental health care provider associated with a lower stage at 
diagnosis? J Oral Maxillofac Surg 2003;61:285-291. 
Horowitz AM, Drury TF, & Canto MT. Practices of Maryland dentists: oral cancer 
prevention and early detection-baseline from 1995. Oral Dis. 2000;6:282-288. 
Huber MA. Assessment of the VELscope as an adjunctive examination tool. Tex Dent 
2009;126:528–35. 
Jaulerry C, Bataini JP, Brunin F, Rodríguez J, & Brugère J. Prognostic factors and results of 
external irradiation of cancers of the base of the tongue. Ann Otolaryngol Chir 
Cervicofac. 1985;102:519-24. 
Johnson NW, Warnakulasuriya S, & Tavassoli M. Hereditary and environmental risk 
factors: clinical and laboratory risk markers for head and neck specials oral, cancer 
and precancer. Eur J Can Prev 1996; 5: 5-17. 
Jovanovic A, Kostense PJ, Schulten EAJM, Snow GB, & van der Waal I. Oral Oncol, Eur J 
Cancer 1992;28B, 37-38. 
Kantola S, Jokinen K, Hyrykangas K, Mäntyselkä P, & Alho OP. Detection of tongue cancer 
in primary care. British Journal of General Practice 2001; 51: 106-111. 
www.intechopen.com
 
Timing of Oral Cancer Diagnosis: Implications for Prognosis and Survival 
 
187 
Kaufman S, Grabau JC, & Lore JH. Symptomatology in head and neck cancer; a quantitative 
review of 385 cases. American Journal of Public Health 1980;70:520-522. 
Kerdpon D, & Sriplung H. Factors related to delay in diagnosis of oral squamous cell 
carcinoma in southern Thailand. Oral Oncology 2001(a);17:127-131. 
Kerdpon D, & Sriplung H. Factors related to advanced stage oral squamous cell carcinoma 
in Southern Thailand. Oral Oncology 2001(b);37:216-221. 
Kowalski LP, Franco EL, Torloni H, et al. Lateness of diagnosis of oral and oropharyngeal 
carcinoma: factors related to the tumour, the patient and health professionals. Oral 
Oncol Eur J Cancer 1994;30B:167-173. 
Kujan O, Glenny AM, Oliver RJ, Thakker N, & Sloan P. Screening programmes for the early 
detection and prevention of oral cancer. Cochrane Database Syst Rev. 2006 Jul 
19;3:CD004150 
Kumar S, Heller RF, Pandey U, Tewari V, Bala N, & Oanh KTH. Delay in presentation of 
oral cancer: a multifactor analytical study. Natl Med J India 2001;14:13-17. 
Lingen MW, Kalmar JR, Karrison T, & Speight PM. Critical evaluation of diagnostic aids for 
the detection of oral cancer. Oral Oncology 2008;44:10–22.36.  
Llewellyn CD, Johnson NW, & Warnakulasuriya KA. Risk factors for oral in newly 
diagnosed patients aged 45 years and younger: a case-control study in Southern 
England. J Oral Pathol Med 2004: 33: 525-332. 
Mashberg A. Eritroplasia vs. Leukoplakia in the diagnosis of early asymptomatic oral 
squamous cell carcinomas. N Engl J Med 1977;297:109-110. 
Mashberg A, & Feldman LJ. Clinical criteria for identifying early oral and oropharyngeal 
carcinoma: Eritroplasia revisited. Am J Surg 1988; 156:273-275. 
Mashberg A, & Samit A. Early diagnosis of asymtomatic oral and oropharyngeal squamous 
cancer. CA-A Cancer Journal for Clinicans 1995; 45: 328-351 
McDowell JD. An overview of epidemiology and common risk factors for oral squamous 
cell carcinoma. Otolaryngol Clin North Am 2006;39:277-94. 
McGurk M, Chan C, Jones J, O’Regan E, & Sherriff M. Delay in diagnosis and its effect on 
outcome in head and neck cancer. British Journal of Oral and Maxillofacial Surgery 
2005;43:281-284. 
McIntosh L, McCullough MJ, & Farah CS. The assessment of diffused Light illumination and 
acetic acid rinse (Microlux/DL) in the visualisation of oral mucosal lesions. Oral 
Oncology 2009;45:E227–31.  
O-charoenrat P, Pillai G, Patel S, et al. Tumour thickness predicts cervical nodal metastases 
and survival in early tongue cancer. Oral Oncology 2003; 39:386–390.  
O’Sullivan EM. Some insights into the potential for the earlier detection of oral cancer: a 
population-based study. In: 7th International Congress on Oral Cancer, April 2001, 
The Hague, Netherlands. Oral Oncol 2001;37:553. 
Onizawa K, Nishihara K, Yamagata K, et al. Factors associated with diagnostic delay of oral 
squamous cell carcinoma. Oral Oncology 2003;39:781-788. 
Parker SL, Tong T, Bolden S, & Wingo PA. Cancer statistics 1996. CA-A Cancer Journal for 
Clinicians 1996;46:5-28. 
Parkin DM, Bray F, Ferlay J, & Pisani P. Global cancer statistics, 2002. CA-A Cancer Journal for 
Clinicans 2005; 55: 74-108. 
Pitiphat W, Diehl SR, Laskaris G, Cartsos V, Douglass CW, & Zavras AI. Factors associated 
with delay in the diagnosis of oral cancer. J Dent Res 2002;81:192-197. 
Po Wing Yuen A, Lam KY, et al. Prognostic factors of clinically stage I and II oral tongue 
carcinoma—a comparative study of stage, thickness, shape, growth pattern, 
www.intechopen.com
 
Oral Cancer 
 
188 
invasive front malignancy grading, Martinez-Gimenco score, and pathologic 
features, Head Neck 2002; 24:513–520 
Porta M, Gallen M, Malats N, & Planas J. Influence of diagnostic delay upon cancer survival: 
an analysis of 5 tumour sites. Journal of Epidemiology and Community Health 
1991;45:225-230. 
Pulte D, & Brenner H. Changes in survival in head and neck cancers in the late 20th and 
early 21st Century, a period analysis. The oncologist 2010; 15: 994-1001. 
Rosenberg D, & Cretin S. Use of meta-analysis to evaluate tolonium chloride in 287oral 
cancer screening. Oral Surg Oral Med Oral Pathol 1989;67:621–7. 
Sargeran K, Murtomaa H, Safavi SM, & Teronen O. Delayed diagnosis of oral cancer in Iran: 
challenge for prevention. Oral Health Prev Dent. 2009;7:69-76. 
Scott SE, Grunfeld EA, & McGurk M. The idiosyncratic relationship between diagnostic 
delay and stage of oral squamous cell carcinoma. Oral Oncology 2005;41:396-403. 
Seoane J, Pita S, Gómez I, Vazquez I, et al. P.Proliferative activity and diagnostic delay in 
oral cancer. Head Neck. 2010 (b); 32(10):1377-84. 
Seoane J, Varela-Centelles PI, Walsh TF, et al. Gingival squamous cell carcinoma: diagnostic 
delay or rapid invasion? J Periodontol. 2006 Jul;77:1229- 33. 
Seoane J, Velo J, Warnakulasuriya S, Varela-Centelles P, et al. Knowledge of oral cancer and 
preventive attitudes of Spanish dentists. Primary effects of a pilot educational 
intervention. Med Oral Patol Oral Cir Bucal. 2010 (a) May 
Spiro R, Huvos A, Wong G, et al. Predictive value of tumour thickness in squamous carcinoma 
confined to the tongue and floor of the mouth. Am J Surg 1986;152:345- 350. 
Teppo H, & Alho OP. Relative importance of diagnostic delays in different head and neck 
cancers.Clin Otolaryngol. 2008 Aug;33(4):325-30. 
Thomsom PJ, & Hamadah O. Cancerisation within the oral cavity: the use of field mapping 
biopsies in clinical management. Oral Oncology 2007;43:20-6.  
Tromp DM, Brouha DR, Hordijk GJ, Winnubst JAM, & Leeuw RJ. Patient and tumour 
factors associated with advanced carcinomas of the head and neck. Oral Oncology 
2005;41:313-319. 
Trullenque -Eriksson A, Muñoz-Corcuera M, Campo-Trapero J, et al. Analysis of new 
diagnostic methods in suspicious lesions of the oral mucosa. Med Oral Patol Oral Cir 
Bucal 2009;14:E210–6.360  
van der Waal I, de Bree R, Brakenhoff R, & Coebergh JW. Early diagnosis in primary oral 
cancer: is it possible? Med Oral Patol Oral Cir Bucal. 2011 May 1;16(3):e300-5. 
Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncology 
2009 Apr-May;45(4-5):309-16. Epub 2008 Sep 18 
Wildt J, Bundgaard T, & Bentzen SM. Delay in the diagnosis of oral squamous cell 
carcinoma. Clin Otolaryngol 1995;20:21-25. 
Woolgar J. Histopathological prognosticators in oral and oropharyngeal squamous cell 
carcinoma. Oral Oncology 2006; 42: 229-239 
Woolgar JA, Rogers S, West C, et al. Survival and patterns of recurrence in 200 oral cancer 
patients treated by radical surgery and neck dissection, Oral Oncology 1999; 35:257– 265 
www.intechopen.com
Oral Cancer
Edited by Dr. Kalu U. E. Ogbureke
ISBN 978-953-51-0228-1
Hard cover, 388 pages
Publisher InTech
Published online 14, March, 2012
Published in print edition March, 2012
InTech Europe
University Campus STeP Ri 
Slavka Krautzeka 83/A 
51000 Rijeka, Croatia 
Phone: +385 (51) 770 447 
Fax: +385 (51) 686 166
www.intechopen.com
InTech China
Unit 405, Office Block, Hotel Equatorial Shanghai 
No.65, Yan An Road (West), Shanghai, 200040, China 
Phone: +86-21-62489820 
Fax: +86-21-62489821
Oral cancer is a significant public health challenge globally. Although the oral cavity is easily accessible, early
diagnosis remains slow compared to the enhanced detection of cancers of the breast, colon, prostate, and
melanoma. As a result, the mortality rate from oral cancer for the past four decades has remained high at over
50% in spite of advances in treatment modalities. This contrasts with considerable decrease in mortality rates
for cancers of the breast, colon, prostate, and melanoma during the same period. This book attempts to
provide a reference-friendly update on the etiologic/risk factors, current clinical diagnostic tools, management
philosophies, molecular biomarkers, and progression indicators of oral cancer.
How to reference
In order to correctly reference this scholarly work, feel free to copy and paste the following:
Pablo Varela Centelles, Juan Manuel Seoane-Romero, Iria Gómez, Pedro Diz-Dios, Nilce Santos de Melo and
Juan Seoane (2012). Timing of Oral Cancer Diagnosis: Implications for Prognosis and Survival, Oral Cancer,
Dr. Kalu U. E. Ogbureke (Ed.), ISBN: 978-953-51-0228-1, InTech, Available from:
http://www.intechopen.com/books/oral-cancer/timing-of-oral-cancer-diagnosis-implications-for-prognosis-and-
survival
© 2012 The Author(s). Licensee IntechOpen. This is an open access article
distributed under the terms of the Creative Commons Attribution 3.0
License, which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
